Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Rhinovirus Infections - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rhinovirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rhinovirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
57 pages
Women Infertility - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
232 pages
Uveitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
266 pages
Axillary Hyperhidrosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
59 pages
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2020
US$ 2,000.00
... . The Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Hypoactive Sexual Desire Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
56 pages
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020
US$ 2,000.00
... . The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
140 pages
Arterial Thrombosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
40 pages
Contact Dermatitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
47 pages
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
80 pages
Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
163 pages
Uveal Melanoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
331 pages
Alcoholic Hepatitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
103 pages
Hand, Foot and Mouth Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
43 pages
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Resistant Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Resistant Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
57 pages
Liver Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
73 pages
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
70 pages
Achondroplasia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
66 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
102 pages
Drug Overdose - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
79 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
209 pages
Hypopharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
September 2020
495 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
270 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
192 pages
Influenzavirus B Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
182 pages
Malignant Pleural Effusion - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
50 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
112 pages
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
35 pages
Heavy Metal Poisoning - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
September 2020
36 pages
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020
US$ 2,000.00
... Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
September 2020
119 pages
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020'; 5-Hydroxytryptamine Receptor...
September 2020
49 pages
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020 SUMMARY 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 13 molecules. Out...
September 2020
76 pages
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020
US$ 3,500.00
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 SUMMARY Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) pipeline Target constitutes close to 27 molecules....
September 2020
122 pages
C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 mo...
September 2020
55 pages
Heparanase - Pipeline Review, H2 2020
US$ 3,500.00
Heparanase - Pipeline Review, H2 2020 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 m...
September 2020
58 pages
High Mobility Group Protein B1 - Pipeline Review, H2 2020
US$ 3,500.00
High Mobility Group Protein B1 - Pipeline Review, H2 2020 SUMMARY High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) - High mobility group box...
September 2020
50 pages
Actinic (Solar) Keratosis - Pipeline Review, H2 2020
US$ 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Actinic (Solar) Keratosis - Pipeline Review, H2 2020, p...
September 2020
69 pages
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020
US$ 3,500.00
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Calcitonin Gene Related Peptide - Pipeline Review, H2 2020'; Calcitonin Gene Related Pept...
September 2020
96 pages
Alzheimer's Disease - Pipeline Review, H2 2020
US$ 2,500.00
... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
1785 pages
Dyslipidemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Dyslipidemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
345 pages
Epilepsy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
662 pages
Atrial Fibrillation - Pipeline Review, H2 2020
US$ 2,000.00
... latest pipeline guide Atrial Fibrillation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Atrial Fibrillation (Cardiovascular) List of TablesNumber of Products under Development for Atrial Fibrillation, H2 2018 9Number of Products under Development ...
August 2020
134 pages
Duchenne Muscular Dystrophy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
413 pages
Genital Herpes - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
123 pages
Osteoarthritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
384 pages
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
184 pages
